China Health Group Ltd. has announced the completion of a significant corporate reorganization involving a discloseable transaction related to a settlement deed. As of July 18, 2025, the company has fulfilled the conditions of the settlement deed, leading to the transfer of its entire equity interest in Jinmei Developments Limited. This move includes the cancellation of a promissory note valued at HK$146 million and the issuance of a settlement note worth HK$12 million to the noteholder. Consequently, Jinmei Developments Limited and its subsidiaries are no longer part of China Health Group's subsidiaries. The announcement was made by Chung Ho, the Chief Executive Officer and Executive Director of China Health Group, underscoring a strategic shift in the company's operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.